Dr Reddys Laboratories (RDY) Free Cash Flow (2024 - 2025)

Dr Reddys Laboratories (RDY) recorded quarterly Free Cash Flow of $238.4 million in Q3 2025, down 5.05% quarter-over-quarter from $251.1 million in Q2 2025, and up 18.5% on a YoY basis from $201.2 million in Q3 2024.

Dr Reddys Laboratories (RDY) Free Cash Flow (2024 - 2025) Analysis & Trends

Dr Reddys Laboratories' Free Cash Flow history runs 2 years deep, the most recent figure standing at $238.4 million for Q3 2025.

  • In Q3 2025, Free Cash Flow rose 18.5% year-over-year to $238.4 million; the TTM figure through Mar 2026 stood at $489.5 million (up 34.37% YoY), while the FY2026 annual figure was $502.0 million, up 9.85% from the prior year.
  • Free Cash Flow was $238.4 million for Q3 2025 at Dr Reddys Laboratories, down from $251.1 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $251.1 million in Q2 2025 to a low of $163.1 million in Q2 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -208.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 291.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 362.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 136.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -38.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -169.83 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 80.53 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 123.09 Mn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 238.42 Mn
Sep 30, 2025 238.42 Mn
Jun 30, 2025 251.10 Mn
Jun 30, 2025 251.10 Mn
Sep 30, 2024 201.20 Mn
Sep 30, 2024 201.20 Mn
Jun 30, 2024 163.10 Mn
Jun 30, 2024 163.10 Mn